Buscar resultados de ensayos clínicos
Inappropriate ADH Syndrome - 16 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Condición:
Fecha: 2005-12-12 Intervenciones: Drug: SR121463B |
Completed |
Nombre del estudio: Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Condición:
Fecha: 2005-12-12 Intervenciones: Drug: SR121463B |
Completed |
Nombre del estudio: Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study Condición: Inappropriate ADH Syndrome Fecha: 2016-03-24 Intervenciones:
|
Withdrawn |
Nombre del estudio: Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine Condición: Syndrome of Inappropriate ADH-secretion Fecha: 2006-03-01 Intervenciones: Procedure: fluid restriction for 14 days (15ml fluid per kg weight) |
Terminated |
Nombre del estudio: A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Condición:
Fecha: 2008-07-31 Intervenciones:
|
Completed |
Nombre del estudio: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Condición: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Fecha: 2013-12-09 Intervenciones: Drug: tolvaptan Subjects will receive a single dose of 3.75, 7.5 or 15 mg of tolvaptan on study Day 1 |
Completed |
Nombre del estudio: Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Condición:
|
Recruiting |
Nombre del estudio: A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH Condición: Syndrome of Inappropriate Antidiuretic Hormone Secretion Fecha: 2017-02-07 Intervenciones: Drug: Tolvaptan Oral Tablet Tolvaptan tablets at 7.5, 15, 30 (one tablet each), or 60 mg (two 30 mg tabl |
Terminated |
Nombre del estudio: Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Condición:
|
Completed |
Nombre del estudio: An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain Condición:
|